| pubmed-article:3139596 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3139596 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:3139596 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:3139596 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:3139596 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
| pubmed-article:3139596 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:3139596 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:3139596 | pubmed:dateCreated | 1988-11-9 | lld:pubmed |
| pubmed-article:3139596 | pubmed:abstractText | Guinea pigs which were injected repeatedly with a mixture of a 3M KCl extract of line 10 tumor and 6-O-(2-tetradecyl-hexadecanoyl)-muramyl-dipeptide (B30-MDP) rejected a tumor graft of line 10. Such an adjuvant effect of B30-MDP was also demonstrated when X-ray-treated line 10 cells were mixed with B30-MDP dissolved in phosphate-buffered saline and inoculated into the animals. | lld:pubmed |
| pubmed-article:3139596 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3139596 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3139596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3139596 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3139596 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:3139596 | pubmed:issn | 0910-5050 | lld:pubmed |
| pubmed-article:3139596 | pubmed:author | pubmed-author:TokunagaTT | lld:pubmed |
| pubmed-article:3139596 | pubmed:author | pubmed-author:KataokaTT | lld:pubmed |
| pubmed-article:3139596 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3139596 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:3139596 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3139596 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3139596 | pubmed:pagination | 817-20 | lld:pubmed |
| pubmed-article:3139596 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:meshHeading | pubmed-meshheading:3139596-... | lld:pubmed |
| pubmed-article:3139596 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3139596 | pubmed:articleTitle | A synthetic adjuvant effective in inducing antitumor immunity. | lld:pubmed |
| pubmed-article:3139596 | pubmed:affiliation | Department of Cellular Immunology, National Institute of Health, Tokyo. | lld:pubmed |
| pubmed-article:3139596 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3139596 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
